Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 15337974.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wrist blockage of median and ulnar nerves before treatment of palmar hyperhidrosis with botulinum toxin (BTX-A) reduces discomfort and improves accuracy of BTX-A injections, but can be associated with mechanical/chemical injury. We sought to compare locoregional anesthesia of median and ulnar nerves using conventional 25-G x 0.50 x 13 mm gauge needle with short 30-G x 0.40 x 6 mm gauge needle. In all, 37 patients with idiopathic, recalcitrant palmar hyperhidrosis were treated with BTX-A after median and ulnar nerve blockage. In 18 patients, a conventional needle was used to achieve nerve blockage and in 19 the short needle was used. The 2 groups of patients were compared for analgesic effects and lag phase. No differences were found between groups for lag phase (P=.26) and discomfort of subsequent BTX-A treatment (P=1.0). The use of a short-gauge needle to block median and ulnar nerves is a suitable method to anesthetize the palm before treatment with BTX-A.
Medical subject headings
- Botulinum Toxins, Type A
- Hyperhidrosis
- Needles
- Nerve Block
- Pain